Insmed Inc. has divulged cathepsin C (dipeptidyl peptidase I, DPP1) inhibitors reported to be useful for the treatment of amyotrophic lateral sclerosis, asthma, metastatic cancer, chronic ...

You take an alpha-glucosidase inhibitor with the first bite of each meal. Most people take a pill three times a day. An alpha-glucosidase inhibitor will usually lower your A1c (the "average" of ...

Janus kinase (JAK) inhibitors were associated with more infections, particularly herpes infections, in patients with atopic dermatitis (AD) compared with biologics, in a cohort study. A ...

Calcitonin gene-related peptide (CGRP) inhibitors are now considered a first-line treatment used to treat and prevent migraines. There are two types of CGRP medications: monoclonal antibodies and ...

Salt Lake City, UT, April 08, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that the ...

A once-daily oral PCSK9 inhibitor reduced LDL in patients with hypercholesterolemia. Safety and tolerability profiles were favorable, according to investigators. CHICAGO — In a phase 2b study ...

After further analysis, the researchers found the drug relies on lysosomes, which are one of the cells' major recycling centers, and on an enzyme called cathepsin B. In Alzheimer's disease ...

Two patients with advanced basal cell carcinoma (BCC) treated with silmitasertib (CX-4945), a CK2 inhibitor, demonstrated progression-free survival (PFS) exceeding 21 months in a phase 1, ...

SAN DIEGO, CA, USA & BERLIN, Germany I April 03, 2025 I Vividion Therapeutics, Inc. (Vividion) today announced that the first patient has been dosed in a Phase I clinical trial evaluating VVD-159642, ...

Get Instant Summarized Text (Gist) A novel probiotic strain, Lactobacillus johnsonii CNCM I-4884, shows enhanced effectiveness against giardiasis, reducing parasite load by 64.4% compared to 48.8% ...